Global Continuous Glucose Monitoring Systems (CGMS) Market (2016-2022)

Thursday, February 23, 2017 Medical Gadgets
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Feb. 22, 2017 /PRNewswire/ -- Continuous Glucose Monitoring Systems (CGMS) market has emerged as a very effective

diabetes management tool used in monitoring all types of diabetic patients. Replacement/repeat sales of components such as sensors would be the major factor that would drive the CGM market growth. Continuous glucose monitoring is very effective in monitoring
patients who are suffering from hypo and hyperglycemic conditions. The CGMS market is expected to reach $3.6 billion by 2022, with a CAGR of 28.2% from 2016 to 2022. Rising incidences of diabetes around the world, benefits of CGMS devices over POC glucometers, growing awareness about diabetes in developing and underdeveloped economies, and growing focus on developing CGMS devices to serve new end user segment are a few leading factors that would drive the growth of CGMS market. FDA approval to the novel and innovative products such as bionic pancreas would also significantly contribute to the market growth of the CGMS market. The CGMS is a relatively more efficient monitoring and treatment system for patients suffering from diabetes. However, lack of effective reimbursement system for devices and clinicians would be a major barrier to the adoption of the devices. The report highlights the adoption of Continuous Glucose Monitoring Systems, globally. Based on the Component, the Global Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The geographies included in the report are North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa). Download the full report: https://www.reportbuyer.com/product/4700266/Key Players profiled in the report includes:Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson. Download the full report: https://www.reportbuyer.com/product/4700266/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com

For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected]  Tel: +44 208 816 85 48 Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-continuous-glucose-monitoring-systems-cgms-market-2016-2022-300411978.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook